Doylestown, PA, United States of America

Dennis J Hlasta

This inventor holds 25 USPTO granted patents, plus 1 CIPO patent and 6 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Janssen Pharmaceutica Nv, Ortho-Mcneil Pharmaceutical Corp., Ortho Pharmaceutical Corporation. Active years: 1998-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dennis J Hlasta. Retrieved from https://idiyas.com/inventor/dennis-j-hlasta

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25

% Patents Active = 76.0

CIPO Patents = 1

EPO Patents = 6 (Patent Applications = 7)

Average Co-Inventor Count = 3.1

ph-index = 6

Forward Citations = 98(Granted Patents)

Company Filing History:

12 out of 2,100

Janssen Pharmaceutica Nv

patents

10 out of 363

Ortho-Mcneil Pharmaceutical Corp.

patents

1 out of 377

Ortho Pharmaceutical Corporation

patents

4. 2 out of 834,453

Other

patents

Years Active: 1998-2014

Loading Chart...

Areas of Expertise:

DPP-1 Inhibitors

Antibacterial Agents

Bicyclic Derivatives

Functionalized Amino Acids

Oxazolidinone

Isoxazoles

Piperidine Derivatives

Endothelial Lipase Inhibitors

Radiolabelled Ligands

Aminoalkylamide Derivatives

Ketolide Antibacterials

Antimicrobial Agents

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8741916 - 1,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as ligands of the ORL-1 receptor (2014-06-03),

2. 8686152 - 4,4-disubstituted piperidine derivatives useful as inhibitors of dipeptidyl peptidase-1 (DPP-1) (2014-04-01),

3. 8633322 - Alkynyl derivatives useful as DPP-1 inhibitors (2014-01-21),

4. 8552032 - Bicyclic derivatives useful as inhibitors of DPP-1 (2013-10-08),

5. 8501937 - Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support (2013-08-06),

6. 8481547 - Substituted benzothiazole and benzoxazole derivatives useful as inhibitors of DPP-1 (2013-07-09),

7. 8476302 - α-ketoamide derivatives useful endothelial lipase inhibitors (2013-07-02),

8. 8216547 - Radiolabelled TRP M8 receptor ligands (2012-07-10),

9. 8168826 - Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support (2012-05-01),

10. 7649055 - Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support (2010-01-19),

11. 7408008 - Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support (2008-08-05),

12. 7259263 - Method of synthesis of azole-containing amino acids (2007-08-21),

13. 6951948 - Method for synthesis of substituted azole libraries (2005-10-04),

14. 6770664 - Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods (2004-08-03),

15. 6683191 - Method for synthesis of substituted azole libraries (2004-01-27),

Title: The Inventor Dennis J Hlasta: Pioneering Innovations in Doylestown

Introduction: Dennis J Hlasta is a distinguished inventor based in Doylestown, PA, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Dennis J Hlasta's latest patents include cutting-edge technologies in the realms of renewable energy, sustainable agriculture, and advanced medical devices, showcasing his versatility and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Dennis J Hlasta has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing solutions that push the boundaries of conventional thinking.

Collaborations: Throughout his career, Dennis J Hlasta has collaborated with leading research institutions, universities, and industry experts to bring his inventions to life, fostering a culture of innovation and knowledge-sharing.

Conclusion: Dennis J Hlasta's passion for innovation, coupled with his relentless drive to make a positive impact on society, solidifies his position as a trailblazing inventor whose work continues to inspire future generations of innovators.

Profile summary based on public USPTO records.